Skip to main content
Farmacosmo logo

Farmacosmo — Investor Relations & Filings

Ticker · ZJ1 ISIN · IT0005487670 LEI · 815600ABEDB6F0BDDE28 XMIL Wholesale and retail trade
Open in API
Filings indexed 188 across all filing types
Latest filing 2026-04-10 M&A Activity
Country IT Italy
Listing XMIL ZJ1

About Farmacosmo

https://www.farmacosmo.com/

Farmacosmo is an e-commerce company that operates an online platform for health, beauty, and personal care products. The company's core business is the online sale of a broad range of items, including parapharmaceuticals, supplements, cosmetics, personal care products, baby supplies, and pet care essentials. Managing its platform in-house, Farmacosmo offers a catalog of over 80,000 products from various brands. The company aims to provide a comprehensive wellness destination by combining the offerings of a pharmacy and a cosmetics retailer, supported by expert advice from professionals.

Recent filings

Filing Released Lang Actions
Il Consiglio Di Amministrazione Approva In Seduta Notarile Il Progetto Di Fusione Per Incorporazione Di Coccar S.R.L. (Pharmasì)
M&A Activity Classification · 85% confidence The document is a press release (comunicato stampa) announcing that the Board of Directors has approved a merger by incorporation of Coccar S.r.l. into Farmacosmo S.p.A. It provides details of the merger approval process under Italian civil code articles, references prior communications, and outlines next steps. This is clearly an M&A-related announcement rather than a full merger agreement or proxy statement. Thus it should be classified under M&A Activity (TAR).
2026-04-10 Italian
Farmacosmo Annuncia La Nomina Di Fabio Scognamiglio Come Nuovo CFO
Board/Management Information Classification · 90% confidence The document is a corporate press release announcing the appointment of Fabio Scognamiglio as the new CFO, replacing the previous CFO who resigned. This is an announcement of a change in senior management. Therefore, it falls under Board/Management Information (Code: MANG).
2026-03-30 Italian
Farmacosmo S.p.A. - Internal Dealing
Director's Dealing Classification · 100% confidence The document is a standard regulatory notification form for 'Internal Dealing' (Director's Dealing), specifically following the EU Market Abuse Regulation (MAR) template for reporting transactions by persons discharging managerial responsibilities. It details specific share purchases by a person exercising administrative functions (Fabio de Concilio) at Farmacosmo S.p.A. This fits the definition of 'Director's Dealing' (DIRS).
2026-03-17 Italian
Avviso Di Convocazione Dell’Assemblea Ordinaria Degli Azionisti
Proxy Solicitation & Information Statement Classification · 100% confidence The document is an official notice of a shareholder meeting (Avviso di Convocazione dell'Assemblea Ordinaria degli Azionisti) for Farmacosmo S.p.A. It provides details on the meeting date, agenda items, and instructions for shareholders to vote via a designated representative. This type of document is a standard proxy solicitation and information statement provided to shareholders to facilitate their participation in corporate governance, fitting the definition of a Proxy Solicitation & Information Statement (PSI).
2026-03-06 Italian
Iscrizione Presso Il Registro Delle Imprese Del Progetto Di Fusione Per Incorporazione Di Coccar S.r.l. (Pharmasì)
M&A Activity Classification · 95% confidence The document is a press release announcing the registration of a merger project (incorporation of Coccar S.r.l. into Farmacosmo S.p.A.) at the Business Register. It details the legal steps taken, the purpose of the merger, and provides links to further documentation. As this document describes a merger and acquisition activity, it falls under the M&A Activity category.
2026-03-02 Italian
Il Consiglio Di Amministrazione Di Farmacosmo Ha Esaminato I Dati Gestionali Consolidati Al 31 Dicembre 2025
Earnings Release Classification · 95% confidence The document is a press release from Farmacosmo S.p.A. announcing preliminary financial results (FY25 revenue) and a corporate merger project (incorporation of Coccar S.r.l.). It provides key highlights of the financial performance and strategic business updates, which is characteristic of an Earnings Release (ER). While it mentions a merger, the primary focus is the communication of the financial data and business performance for the fiscal year ending December 31, 2025. FY 2025
2026-02-24 Italian

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.